Back to top
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Intuitive Surgical, Inc. (ISRG) - $25 value - yours FREE >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Intuitive Surgical, Inc. (ISRG) - $25 value - yours FREE >>
Image: Bigstock
Intuitive Surgical at 52-Week High on High Procedural Volume
Share price of Intuitive Surgical (ISRG - Free Report) rallied to a new 52-week high of $661.94 on Jun 23, eventually closing a tad bit lower at $661.32. This represents a strong one-year return of about 33.64%, much better than the S&P 500’s return of 0.52% over the same time frame.
Currently, Intuitive Surgical carries a Zacks Rank #3 (Hold). The stock has a market cap of 25.17 billion and a long-term expected earnings growth rate of 11.26%.
Key Catalysts
Intuitive Surgical reported an impressive first quarter of 2016 with exceptional global procedure growth, solid capital placement, strong product margin and new product launches. Notably, the company reported adjusted earnings of $3.67 per share, which beat the Zacks Consensus Estimate by 21 cents.
INTUITIVE SURG Price and Consensus
INTUITIVE SURG Price and Consensus | INTUITIVE SURG Quote
Strong procedural volumes of da Vinci System (robot-assisted surgery system) in U.S. and international markets was a major growth catalyst. Intuitive Surgical shipped about 110 da Vinci Systems in the first quarter (99 in the year-ago quarter). Worldwide, da Vinci procedures grew nearly 17% from the first quarter of 2015.
Intuitive Surgical’s expanding product line is also a significant positive for the long term. The recent FDA approval of the ‘Integrated Table Motion’ for da Vinci Xi Surgical System (in collaboration with Hill-Rom Holdings) is a noteworthy development for the company. This has also been accompanied by the launch of 30-millimeter Xi stapler, Xi Single Site Instrument and clinical usage of SP products, which are likely to propel growth for the company.
Estimate Revisions
The Zacks Consensus Estimate for fiscal 2016 decreased by 11 cents to $17.56 over the last 60 days. Similarly, for fiscal 2017, estimates dropped by 7 cents to $20.51 over the same time frame.
Key Picks
Better-ranked stocks in the sector include CryoLife Inc , IRadimed Corp (IRMD - Free Report) and Masimo Corp. (MASI - Free Report) . All the three stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>